Alkem Laboratories to invest Rs 30 crore in HaystackAnalytics

06 Jun 2024 Evaluate

Alkem Laboratories has planned to invest an amount of Rs 30 crore in the (Pre-Series A) Compulsorily Convertible Preference Shares of HaystackAnalytics. The proposed investment is a strategic investment by the company. It will help the company to participate in growing diagnostic space and leveraging Haystack's expertise in advanced genomic data analysis to drive its business based on the detailed analytics from the generated reports. The said transaction is expected to be completed on or before July 31, 2024 or such extended period as may be agreed upon. 

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.


Alkem Laboratories Share Price

5431.85 -65.55 (-1.19%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.